dGH™ Platform
Our proprietary dGH™ technology enables high-resolution, single-cell detection of chromosomal changes, including inversions, deletions, translocations, transgene insertion, and complex chromosome abberations.
Remove the Guesswork
Highly differentiated technology provides the definitive structural variant analysis for genomic integrity.
Achieve Gene Editing Excellence with KromaTiD’s dGH™ Platform
Leverage KromaTiD’s advanced dGH platform for a thorough evaluation and optimization of your gene editing.
Our assays and analytics enumerate and locate off-target events and other genomic alterations, providing critical insights into genomic integrity. This data informs the development of your gene-edited therapies and supports their regulatory requirements.
Our collaborative approach employs innovative strategies to measure the success of gene editing. Through close collaboration with our industry partners, KromaTiD provides world class genomic integrity and stability data, scientific and technical support, and analysis across your entire therapeutic pipeline.
Together, we’ll achieve unparalleled precision and reliability in gene editing. By combining our expertise with yours, KromaTiD elevates industry standards and pushes the boundaries of genomic innovation.